Compare Hims and Hers Health Inc (HIMS) vs Starbucks Corp (SBUX) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Starbucks (SBUX) trades at $104.64, down 0.81% on the day, with a bullish technical outlook supported by moving averages. The stock shows mixed earnings performance, missing estimates in Q3 and Q4 2025 but beating in Q1 2026, while revenue growth remains steady. Recent news highlights cost-cutting initiatives, including a $400 million AI-driven software reduction plan, and strong channel development growth of 39% year-over-year in Q2 2026.

The investment outlook is cautiously optimistic, with a consensus price target of $108.86 offering modest upside. Key opportunities include margin expansion from cost efficiencies and dividend growth, but risks involve high valuation multiples, competitive pressures, and inconsistent earnings performance. Analyst sentiment is balanced with 47% buy and hold ratings each.